Coverage
-
May 31, 2023
Bayer Corp. is pushing back against a bid for attorney fees by the former legal team of a whistleblower who secured a more than $40 million settlement in suits in New Jersey and Minnesota alleging the company downplayed the risks of some of its drugs, saying their requests for millions in fees should be either substantially reduced or nixed altogether.
4 other articles on this case.
View all »